Evaluating the Differential Effects of Valproic Acid on Wharton’s Jelly Mesenchymal Stem Cells
Purpose: The histone deacetylases (HDAC) inhibitor, valproic acid (VPA), is a common antiepileptic drug and is attractive for its broad range of therapeutic effects on many diseases. It has been employed as an inducer of pluripotency in some cultured cells. Conversely, VPA has also been employed as...
Main Authors: | Homa Salami, Seyed Javad Mowal, Rasoul Moukhah, Zahra Hajebrahimi, Seyed Abdolhakim Hosseini, Houri Edalat |
---|---|
Format: | Article |
Language: | English |
Published: |
Tabriz University of Medical Sciences
2019-08-01
|
Series: | Advanced Pharmaceutical Bulletin |
Subjects: | |
Online Access: | https://apb.tbzmed.ac.ir/PDF/apb-26465 |
Similar Items
-
Wharton's Jelly Derived-Mesenchymal Stem Cells: Isolation and Characterization
by: Hossein Ranjbaran, et al.
Published: (2018-02-01) -
Wharton’s jelly absence: a possible cause of stillbirth
by: Eduarda Bittencourt Damasceno, et al.
Published: (2013-12-01) -
Differentiation of Wharton's Jelly Derived Mesenchymal Stem Cells into Insulin Producing Cells
by: Hossein Ranjbaran, et al.
Published: (2018-07-01) -
Isolation and Characterization of Feline Wharton’s Jelly-Derived Mesenchymal Stem Cells
by: Min-Soo Seo, et al.
Published: (2021-02-01) -
Comparative Analysis of Mesenchymal Stem Cells Isolated from Human Bone Marrow and Wharton’s Jelly
by: Narges Talebian, et al.
Published: (2013-05-01)